Bibliography
- ARLT W, ALLOIO B: Adrenal insufficiency. Lancet (2003) 361:1881-1893.
- ANDRIOLI M, PECORI GIRALDI F, Cavagnini F: Isolated corticotrophin deficiency. Pituitary (2006) 9:289-295.
- SPEISER P, WHITE P: Congenital adrenal hyperplasia. N. Engl. J. Med. (2003) 349:776-788.
- MAH PM, JENKINS RC, ROSTAMI-HODJEGAN A et al.: Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin. Endocrinol. (2004) 61:367-375.
- CROWN A, LIGHTMAN S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin. Endocrinol. (2005) 63:483-492.
- PECORI GIRALDI F, FATTI L, CAVAGNINI F: Isolated corticotrophin deficiency presenting with pericardial effusion. J. Endocrinol. Invest. (2005) 28:831-833.
- VALERO MA, LEON M, RUIZ VALDEPENAS M et al.: Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Miner. (1994) 26:9-17.
- WICHERS M, SPRINGER W, BIDLINGMAIER F et al.: The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hyocortisolism. Clin. Endocrinol. (1999) 50:759-765.
- THOMSEN AF, KVIST TK, ANDERSEN PK et al.: The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology (2006) 31:614-622.
- GARCIA-BORREGUERO D, WEHR TA, LARROSA O et al.: Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. (2000) 85:4201-4206.
- LI VOON CHONG JS, SEN J, JOHNSON Z et al.: Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism. Clin. Endocrinol. (2001) 54:267-271.
- NICHOLSON G, BURRIN JM, HALL GM: Peri-operative steroid supplementation. Anesthesia (1998) 53:1091-1104.
- HAHNER S, ALLOIO B: Management of adrenal insufficiency in different clinical settings. Expert Opin. Pharmacother. (2005) 6(14):2407-2417.
- FEEK CM, RATCLIFFE JG, SETH J et al.: Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin. Endocrinol. (1981) 14:451-458.
- PUTIGNANO P, TOJA P, DUBINI A: Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J. Clin. Endocrinol. Metab. (2003) 88:4153-4157.
- FLAD TM, CONWAY JD, CUNNINGHAM SK et al.: The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency. Clin. Endocr. (1996) 45:529-534.
- HUNT PJ, GURNELL EM, HUPPERT FA et al.: Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. (2000) 85:4650-4656.
- LIBÈ R, BARBETTA L, DALL'ASTA C et al.: Effects of DHEA supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. Clin. Endocrinol. (2004) 27:736-741.
- MERKE DP, BORNSTEIN S: Congenital adrenal hyperplasia. Lancet (2005) 365:2125-2136.
Patents
- SOC. POUR L'IND. CHIM. A BALE: CH196871 (1938).
- RESEARCH INSTITUTE MEDICINE CHEMISTRY, INC.: DE1916010 (1969).
- FARBWERKE HOECHST AG: DE2260384 (1074).
- SCHERING AG: DE892450 (1953).
- UPJOHN CO.: GB869511 (1959).
- UPJOHN CO.: US2793159 (1957).
- MERCK PATENT GMBH: DE4318577 (1994).